A randomized trial of peginterferon alpha-2a with or without ribavirin for HBeAg-negative chronic hepatitis B.

Rijckborst V;ter Borg MJ;Cakaloglu Y;Ferenci P;Tabak F;Akdogan M;Simon K;Raptopoulou Gigi M;Ormeci N;Zondervan PE;Verhey E;van Vuuren AJ;Hansen BE;Janssen HL;PARC Study G.r.o.u.p. CollaboratorsMunda P;Scherzer TM;Staufer K;Vogel W;Graziadei I;Gerken G;Niederau C;Germanidis G;Hatzis G;Kitis G;Xiarchos P;Gigi E;Sinakos E;Vafiadis Zouboulis I;Nicolaou P;Paraskevi G;Grima P;Montalto G;Russello M;Scifo G;SPADARO, Aldo;Tripi S;op den Brouw ML;Diepstraten SD;van Doornum GJ;van der Ent C;Heijens A;Keizerwaard A;Ouwendijk M;Ramdjan G;van Santen LA;Scherbeijn SM;Schutten M;Tielemans W;Woltman AM;Woltman R;Lapinski TW;Halota W;Mach T;Pazgan Simon M;Akarca US;Ersoz G;Sasmaz N;Pinarbasi B;Balik Z;Senturk H.

2010-01-01